富血小板血浆市场规模、份额、成长分析，按类型、来源、应用、最终用户、地区 - 产业预测，2024-2031 年

2022年，全球富血小板血浆市场规模为4.7853亿美元，从2023年的5.3978亿美元成长到2031年的14.1479亿美元，预计在复合年增长率预测期内（2024-2031年）将成长。为12.8%。

富血小板血浆（PRP）注射市场作为治疗方法各种疾病的有效方法，尤其是脱髮和运动损伤，正在迅速普及。这种创新手术利用患者自身的血球来促进目标区域的癒合和恢復。事实证明，PRP 注射可有效解决肌肉骨骼损伤，显着加快恢復时间，减轻疼痛，并促进网球肘和跳高膝等慢性疾病更快恢復活动。 PRP 在外科手术和再生医学的应用不断增加，为广泛的医学研究铺平了道路，并进一步推动市场成长。这一趋势的推动因素是运动伤害发生率的增加以及 PRP 在牙科和牙周手术中的应用不断增加。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 监管环境
• 专利分析
• 案例研究

按类型分類的富血小板血浆市场规模和复合年增长率（2024-2031）

• 市场概况
• 纯富血小板血浆 (P-PRP)
• 含有白血球 (L-PRP) 的富含血小板血浆
• 含白血球纤维蛋白 (L-PRF)
• 其他的

依来源地和复合年增长率分類的富血小板血浆市场规模（2024-2031）

• 市场概况
• 自体富血小板血浆
• 同种异体富血小板血浆
• 同种异体富血小板血浆

按应用和复合年增长率分類的富血小板血浆市场规模（2024-2031）

• 市场概况
• 整形外科和脊椎外科
• 整容手术及美容
• 一般外科
• 神经外科
• 其他的

富血小板血浆市场规模：依最终用户和复合年增长率（2024-2031）

• 市场概况
• 医院和诊所
• 调查机构
• 其他的

富血小板血浆市场规模与复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Harvest Technology（USA）
• Stryker Corporation（USA）
• Zimmer Biomet（USA）
• Arthrex Inc.（USA）
• Terumo BCT Inc.（USA）
• Celling BioSciences Inc.（USA）
• APEX Biologix（USA）
• Juventix Regenerative Medical, LLC（Italy）
• Dr. PRP USA LLC（USA）
• Ycellbio Medical Co., Ltd.（South Korea）
• EmCyte Corporation（USA）
• Regen Lab SA（Switzerland）
• Zimmer Biomet（USA）
• Arthrex Inc.（USA）
• Terumo BCT Inc.（USA）
• Celling BioSciences Inc.（USA）

结论和建议

Global Platelet Rich Plasma Market size was valued at USD 478.53 million in 2022 and is poised to grow from USD 539.78 million in 2023 to USD 1414.79 million by 2031, growing at a CAGR of 12.8% during the forecast period (2024-2031).

The market for platelet-rich plasma (PRP) injections is experiencing a surge in popularity as effective treatments for various conditions, particularly hair loss and sports injuries. This innovative procedure utilizes the patient's own blood cells to enhance healing and recovery in targeted areas. PRP injections have demonstrated efficacy in addressing musculoskeletal injuries, significantly accelerating recovery times, reducing pain, and facilitating quicker returns to activity for chronic conditions like tennis elbow and jumper's knee. The rising adoption of PRP in surgical and regenerative medicine has opened avenues for extensive medical research, further fueling market growth. This trend is bolstered by an increasing incidence of sports injuries, as well as the expansion of PRP applications in dental and periodontal surgeries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Platelet Rich Plasma market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Platelet Rich Plasma Market Segmental Analysis

Global Platelet Rich Plasma Market is segmented by type, origin, application, by end-user and region. Based on type, the market is segmented into pure platelet rich plasma (P-PRP), leukocyte-rich platelet rich plasma (L-PRP), leukocyte-rich fibrin (L-PRF) and others. Based on origin, the market is segmented into autologous PRP, allogeneic PRP and homologous PRP. Based on application, the market is segmented into orthopedic and spinal surgery, cosmetic surgery and aesthetics, general surgery, neurosurgery and others. Based on end-user, the market is segmented into hospitals and clinics, research institutes and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Platelet Rich Plasma Market

The Platelet Rich Plasma (PRP) market is driven by a significant increase in demand for PRP treatments in orthopaedic disorders, musculoskeletal issues, and sports injuries. This surge can be attributed to PRP's ability to harness growth factors that enhance healing processes. As a personalized regenerative medicine approach, PRP is vital in promoting wound healing and restoring tissue, leading to its extensive application in managing conditions like osteonecrosis and post-tooth extraction healing. Additionally, the versatile use of PRP in aesthetic procedures such as skin rejuvenation, acne scar treatment, and alopecia further fuels market growth, owing to its effectiveness in stimulating collagen production and extracellular matrix reconstruction. As various therapeutic advancements are anticipated, the PRP market is poised for robust expansion in the coming years.

Restraints in the Global Platelet Rich Plasma Market

The anticipated growth of the global platelet rich plasma market during the forecast period is likely to face significant challenges due to the increasing fluctuations in the pricing of platelet-rich plasma therapy. Additionally, the market's expansion could be further restricted by concerns related to quality control and the reliability of test results. Furthermore, the necessity for official FDA approval for specific end-use applications adds another layer of complexity, which may hinder overall market development. These factors combine to create a challenging environment that could stifle the potential growth of the platelet rich plasma market in the coming years.

Market Trends of the Global Platelet Rich Plasma Market

The Global Platelet Rich Plasma (PRP) market is witnessing significant growth, largely fueled by its effectiveness in enhancing hair density and promoting hair follicle development. As PRP is derived from the patient's own blood, it presents a compelling advantage due to its safety profile, minimizing risks of infectious diseases. This innovative treatment is increasingly sought after as both a standalone procedure and in conjunction with hair transplants. Despite the mild side effects commonly associated with PRP, ongoing research aims to solidify its efficacy and establish standardized protocols, ensuring optimal patient outcomes while expanding the market's reach across therapeutic applications.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Platelet Rich Plasma Market Size by Type & CAGR (2024-2031)

• Market Overview
• Pure Platelet Rich Plasma (P-PRP)
• Leukocyte-Rich Platelet Rich Plasma (L-PRP)
• Leukocyte-Rich Fibrin (L-PRF)
• Others

Global Platelet Rich Plasma Market Size by Origin & CAGR (2024-2031)

• Market Overview
• Autologous PRP
• Allogeneic PRP
• Homologous PRP

Global Platelet Rich Plasma Market Size by Application & CAGR (2024-2031)

• Market Overview
• Orthopedic and Spinal Surgery
• Cosmetic Surgery and Aesthetics
• General Surgery
• Neurosurgery
• Others

Global Platelet Rich Plasma Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Hospitals and Clinics
• Research Institutes
• Others

Global Platelet Rich Plasma Market Size & CAGR (2024-2031)

• North America (Type, Origin, Application, End-User)
  • USA
  • Canada
• Europe (Type, Origin, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Origin, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Origin, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Origin, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Harvest Technology (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo BCT Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celling BioSciences Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• APEX Biologix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Juventix Regenerative Medical, LLC (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. PRP USA LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ycellbio Medical Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EmCyte Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regen Lab SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo BCT Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celling BioSciences Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations